Elisa Lodi Rizzini

6PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersRadiation and matterHaematological tumoursTumour immunologyVeterinary diagnosis and diagnostics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 13, 2025
Large Italian Multicenter Study on Prognostic Value of Baselines Variables in mCRPC Patients Treated with 223RaCl2: Ten Years of Clinical Experience.

Maria Silvia De Feo, Luca Filippi, Matteo Bauckneht

|May 16, 2023
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study.

Maria Silvia De Feo, Viviana Frantellizzi, Matteo Bauckneht

|Dec 23, 2022
Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value.

Cristina Mosconi, Alberta Cappelli, Cinzia Pettinato

|Apr 12, 2022
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study.

Matteo Bauckneht, Sara Elena Rebuzzi, Marta Ponzano

|Aug 27, 2021
Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC).

Elisa Lodi Rizzini, Andrea Repaci, Elena Tabacchi

|Aug 07, 2021
Usefulness of PET/CT with 18F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study.

Luca Filippi, Viviana Frantellizzi, Fabio Monari

Pageof 1

Frequent Collaborators

4 joint publications

Viviana Frantellizzi

4 joint publications

Giuseppe De Vincentis

3 joint publications

Luca Filippi

3 joint publications

Giuseppe Rubini